Tsumura & Co
TSE:4540

Watchlist Manager
Tsumura & Co Logo
Tsumura & Co
TSE:4540
Watchlist
Price: 4 858 JPY -0.59% Market Closed
Market Cap: 368.9B JPY
Have any thoughts about
Tsumura & Co?
Write Note

Relative Value

The Relative Value of one Tsumura & Co stock under the Base Case scenario is 4 856.97 JPY. Compared to the current market price of 4 858 JPY, Tsumura & Co is Fairly Valued.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
4 856.97 JPY
Fairly Valued
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
7
vs Industry
52
Median 3Y
1.7
Median 5Y
1.8
Industry
2.5
Forward
2
vs History
47
vs Industry
26
Median 3Y
13
Median 5Y
14.3
Industry
21.9
Forward
12.2
vs History
39
vs Industry
7
Median 3Y
16.1
Median 5Y
15.1
Industry
16.5
vs History
vs Industry
3
Median 3Y
6.7
Median 5Y
8.4
Industry
23.6
vs History
4
vs Industry
58
Median 3Y
0.9
Median 5Y
1
Industry
2.1
vs History
4
vs Industry
53
Median 3Y
1.6
Median 5Y
1.7
Industry
2.6
Forward
1.9
vs History
3
vs Industry
47
Median 3Y
3.1
Median 5Y
3.1
Industry
5.2
vs History
20
vs Industry
35
Median 3Y
6.8
Median 5Y
7.5
Industry
13.3
Forward
6.8
vs History
30
vs Industry
30
Median 3Y
10
Median 5Y
10.5
Industry
16.6
vs History
36
vs Industry
8
Median 3Y
15.6
Median 5Y
14.1
Industry
15.6
vs History
1
vs Industry
5
Median 3Y
19.3
Median 5Y
20.6
Industry
19.1
vs History
4
vs Industry
62
Median 3Y
0.8
Median 5Y
0.9
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Tsumura & Co Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Tsumura & Co
TSE:4540
368.9B JPY 2.2 14.6 8.5 11.6
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
JP
Tsumura & Co
TSE:4540
Average P/E: 30.2
14.6
103%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top